Renal failure and rhabdomyolysis associated with sitagliptin and simvastatin use. but what about the amiodarone?: Letters: Correspondence

Diabetic Medicine

Volumn 26, Issue 2, 2009, Pages 192-193

  Boucher, B J ^a  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; SIMVASTATIN; SITAGLIPTIN;

ALLELE; GENETIC RISK; GENETIC VARIABILITY; HUMAN; KIDNEY FAILURE; LETTER; RHABDOMYOLYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYMPTOMATOLOGY;

AMIODARONE; ANTILIPEMIC AGENTS; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; DRUG THERAPY, COMBINATION; GREAT BRITAIN; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KIDNEY FAILURE; MALE; ORGANIC ANION TRANSPORTERS; PYRAZINES; RHABDOMYOLYSIS; SIMVASTATIN; TRIAZOLES; UNITED STATES;

EID: 60049094083     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2008.02659.x     Document Type: Letter

References (5)

1. Kao DP, Kohrt HE, Kugler J. Renal failure and rhabdomyolysis associated with sitagliptin and simvastatin use. Diabet Med 2008 25 : 1229 1230.
2. SEARCH Study Collaborative Group. Study of the effectiveness of additional reductions in cholesterol and homocysteine (SEARCH): characteristics of a randomized trail among 12 064 myocardial infarction survivors. Am Heart J 2007 154 : 815 823.
3. British Medical Association/Royal Pharmaceutical Society of Great Britain. British National Formulary. London, UK : BMJ Publishing Group, RPS Publishing, 2007.
4. Electronic Medicines Compendium. Zocor datasheet. 2007. Available at http://www.emc.medicines.org.uk/emc/assets/c/html/DisplayDoc.asp?DocumentID= 1201 Last accessed 28 July 2008.
5. The SEARCH Collaborative Group. SLCO1B1 variants and statin-induced myopathy - a genomewide study. New Eng J Med 2008 359 : 789 799.